ABSTRACT A synergistic interaction in the proliferative response to alloantigen has been previously noted when intact thymus cells are cultured with post-thymic (peripheral) lymphoid cells. In the present study, a factor extracted from the thymus has been shown to similarly enhance the reactivity of syngeneic lymph node cells and thus to retain the amplifier activity of intact thymus cells. The factor has no effect on lymphoid cell proliferation in the absence of alloantigen. Cells with amplifier activity are found in highest concentration in the thymus but also may be detected in spleen cells that are nonadherent to nylon wool. The factor is shown in these experiments to be derived from thymic Iymphoid cells and to act primarily upon post-thymic (peripheral) lymphoid cells. As such, this factor appears to be distinct from various other thymus factors that have been localized to thymic reticuloepithelial elements and that are thought to effect predominantly the differentiation of T-cell precursors.
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A synergistic interaction between subpopulations of thymusderived lymphocytes has been observed for the response to alloantigens in both in vivo and in vitro assays. In the initial demonstration of this phenomenon, Cantor and Asofsky (1) identified two distinct subpopulations of lymphoid cells involved in the graft-versus-host response in mice. One lymphoid cell (a precursor or T1 cell) was found in highest concentration in the thymus and spleen; a second cell type (an amplifier or T2 cell) was found in highest concentration in the peripheral blood and lymph nodes. Mixtures of T1 and T2 cells resulted in a greater response than would be expected from the sum of the reactivities of the two cell types tested separately (1) . In subsequent studies, synergy between subpopulations of responding cells in vitro has been observed for both mixed leukocyte culture (MLC) (2) (3) (4) (5) (6) (7) and cell-mediated lympholysis (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) assays. Although synergy was first demonstrated in mixtures of thymus and peripheral T cells, more recently synergy has been observed between subclasses of peripheral T cells (8) (9) (10) . Little is known concerning the mechanism of T-cell synergy. A requirement for actual cell-to-cell contact has been assumed, although a soluble product of activated T cells has been reported in one study to substitute for intact amplifier cells in a cell-mediated lympholysis assay (19) .
In the present study, a factor extracted from rat thymus is shown to amplify the proliferative response of syngeneic cells to alloantigen. This factor appears to be in highest concentration in thymus lymphoid cells (thymocytes) and may therefore be distinct from the various factors (thymic factor, thymosin, thymopoietin, etc.) that have been localized to thymic reticuloepithelial elements. The tissue distribution and the target cell for this new thymus factor are defined.
MATERIALS AND METHODS Animals. Inbred Wistar Furth (W/Fu) and Brown Norway (RN) male rats were purchased from Microbiological Associates (Walkersville, MD).
Lymphocyte Cultures. Extra-high amino acid (EHAA) medium was prepared as described by Peck and Bach (20) . Single lymphoid cell suspensions were prepared in Eagles minimal essential medium. Nonadherent spleen cells were obtained by passage through columns of nylon wool, a procedure that presumably enriches for T cells (21) . Cells were washed three times in Eagle's medium and resuspended in serum-free EHAA medium (or cell extract) at the starting concentration in 0.1 ml. Stimulating cells were exposed to xirradiation [a total dose of 2000 R [0.5 C/kg] delivered at 200 R/min from a '37Cs source). The proliferative activity of cultures was determined by procedures described elsewhere (22) .
Fractionation of Thymus Cells. Thymii were aseptically excised from 3-week-old male W/Fu rats and cell suspensions were incubated for 24 hr. The nonadherent cell fraction was defined as those cells recovered after gentle decantation of the cell mixture after this incubation period. Wright-Giemsastained smears of this nonadherent cell fraction revealed only lymphoid cells. Reticuloepithelial cells were not detected.
Thymic reticuloepithelial cultures were prepared in a similar manner, except that after 24 hr of incubation the nonadherent cells were removed, and the remaining adherent cell cultures were maintained in Waymouth's tissue culture medium supplemented with 20% fetal calf serum. The lymphoid cells failed to survive under these conditions and were undetectable in cultures after 3-4 days of incubation. Secondary cell monolayers were used in these experiments to exclude products derived from thymocytes originally contaminating the cultures and to ensure adequate cell numbers for the preparation of extract (23) .
Thymocytes were depleted by an antiserum prepared in a goat by immunization with W/Fu thymus cells (24) . This serum was rendered specific for rat thymocytes by absorption with bone marrow cells obtained from "B" rats (25) . Serum Pretreatment of W/Fu thymus cells with an anti-rat thymocyte serum plus complement resulted in complete loss of amplifier activity (Fig. 2) . Pretreatment of thymus cells with the control serum plus complement resulted in, if anything, a slight increase in the amplifier activity of the treated cells. The extract prepared from the thymus cells exposed to antiserum and complement was neither toxic nor stimulatory to W/Fu lymph node responding cells in the absence of alloantigen.
Selective Amplification of Different Responding Cell Types by Thymus Extract. The experiment illustrated in Fig.  3 demonstrates that an extract prepared from syngeneic W/Fu thymus cells expresses the capacity to enhance selectively the proliferative response of lymph node and column-passed spleen cells in response to alloantigens. Responding cells from various lymphoid tissues were incubated with identical aliquots of a W/Fu thymus extract and with alloantigen. Results are expressed as the increment observed in the proliferative response of the cells after the addition of the thymus extract. The results suggest that the factor may specifically interact with subpopulations of responding cells with restricted lymphoid tissue distribution. As in the experiments described in preceding sections, the differences observed in the response of the various cell types after the addition of thymus extract could not be explained by differences in either respond to an alloantigenic stimulus by proliferation or to amplify the response of other cells in lymphoid cell mixtures. The thymus contains cells that directly respond by proliferation and that have the potential to enhance indirectly the response of peripheral lymphoid cells in mixtures, a potential which does not require their proliferation.
In the present series of experiments, a factor extracted from thymus has been shown to retain amplifier activity comparable to that of intact thymus cells. Several facts concerning this factor have been established. (i) The thymus factor has been shown to amplify the proliferative response of lymphoid cells to alloantigen but to have no effect on lymphoid cell proliferation in the absence of alloantigen. (ii) The factor is extracted from a cell present in highest concentration in the thymus and a Tcell enriched fraction from spleen; extracts prepared from lymph node, whole spleen, or bone marrow were found to be devoid of amplifier activity. (iii) The thymus factor has been shown to amplify selectively the proliferative response of certain lymphoid cell types, and maximal activity was achieved when the factor was added to cultures of lymph node cells or nonadherent spleen cells; by contrast, the factor had little effect on the proliferative response of thymus, whole spleen, or bone marrow cells. (iv) The factor has been localized to thymic lymphoid cells, rather than thymic reticuloepithelial elements, a conclusion supported by two independent lines of evidence: first, amplifier activity was shown to be present in a fraction of nonadherent thymus cells and undetectable in cultures of thymic reticuloepithelial cells (Table 2) ; and second, amplifier activity was shown to be abolished by pretreatment of thymus cells with a specific anti-rat thymocyte serum plus complement (Fig. 3) . These results do not exclude the possibility that the factor may be present in a minor subpopulation of nonadherent reticuloepithelial cells, although it should be noted that no epithelial elements were recognizable morphologically from smears made of preparations of nonadherent thymus cells.
These observations suggest that the factor is derived from and acts upon cells that have a restricted tissue distribution. The thymus represents the richest source of cells with amplifier activity. The lymph node contains cells that may respond but that have little amplifier activity themselves. The spleen contains cells with both functions; the bone marrow has neither.
The coexistence in spleen of subpopulations of lymphoid cells with amplifier and responder activities has been suggested by other experiments identifying cells that manifest differences in "homing" patterns in lethally irradiated mice (28, 29) , in susceptibility to treatment with ALS and irradiation (8) , and in Ly phenotype (9) (10) . It is of interest to note in this regard that, although preparations of nonadherent spleen cells could both serve as a source of amplifier activity and respond to amplifier, preparations of whole spleen could do neither. This observation could be most readily explained by the presence of a population of adherent spleen cells that inhibit amplifier activity. There is, however, no direct evidence documenting the existence of this suppressor cell population.
The relationship between the thymus factors defined by the present series of experiments and the various previously described thymus factors requires special comment. The bestcharacterized of these factors-thymosin (30) (31) (32) , thymopoietin (33) (34) (35) , and thymic factor (36-39)-have all been reported to be derived from thymic reticuloepithelial elements rather than thymus lymphoid cells. The effect of these factors on the MLC response of normal syngeneic lymphoid cells has been variable. Cohen et al. (40) reported that the addition of thymosin to one-way MLCs resulted in an increase in the proliferative response of thymus cells but a decrease in the response of spleen cells to alloantigen. Another thymus product, thymus humoral factor, is also assumed to be a product of the reticuloepithelial cells of the thymic medulla, although its cellular origin is less well-defined than in the case of the factors discussed above (41) (42) (43) . Thymus humoral factor has been observed to either increase or decrease MLC reactivity, depending upon the assay conditions utilized. Preincubation of responding thymus or spleen cells with thymus humoral factor for 1 hr was reported to increase their "MLC competence." If thymus humoral factor was not washed from the responding cells but was allowed to remain in the culture medium throughout the 4-day period of assay, however, a substantial decrease in the MLC response was observed (44, 45) . Evidence has been presented that the prime target cells for thymus humoral factor are "young" thymus-derived lymphocytes (46) and that the effects of thymus humoral factor on these cells may be explained by rapid alterations in the cellular concentration of cyclic AMP (47) .
By comparison, the factor identified in the present study can be distinguished from any of the previously described thymus factors because: first, it is derived from thymic lymphoid cells rather than from the thymic reticuloepithelial cells; second, it may also be detected in a subpopulation of spleen cells rather than restricted to thymus cells; and third, its target cell is a post-thymic lymphoid cell, rather than an immature T-cell precursor.
The relationship of this factor to other previously described thymus factors could presumably be more explicitly established were our material to be critically compared with known factors by the few laboratories that have developed the capability to perform such analyses. The physiological role of any of these thymus factors, if any, has yet to be clearly defined.
